Apotex Corp. and Centric Health Resources team up to help liver transplant patients obtain seamless care
Apotex Corp., maker of HepaGamB, and specialty pharmacy company Centric Health Resources have launched a program to help liver transplant patients transition from hospital to home. The HepaGamB Aftercare Access Program enables patients to receive the hepatitis B immune globulin intravenous (human) at home along with educational information, nursing services, help with obtaining reimbursement, and on-call support. More information is available at 1-(866) 588-6932.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.